REQUEST A DEMO
Total
USD $0.00
Search more companies

SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Spetsializirana Bolnitsa Za Aktivno Lechenie Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Specialized hospital for active treatment of infectious and parasitic diseases was registered as a joint stock company, fully-owned by the State, in 2000. The main activity of the hospital is diagnostics and active treatment of infectious and parasitic diseases.

Headquarters
bul. Akad. Ivan Evstratiev Geshov 17
Sofia; Sofia - city; Postal Code: 1606

Contact Details: Purchase the SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report to view the information.

Basic Information
Total Employees:
Purchase the SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report to view the information.
Outstanding Shares:
Purchase the SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report to view the information.
Registered Capital:
Purchase the SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report to view the information.
Financial Auditors:
Purchase the SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report to view the information.
Incorporation Date:
September 20, 2000
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after SBAL Po Infektsiozni 1 Parazitni Bolesti Prof. Ivan Kirov EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
101.11%
Total operating revenue
31.78%
Operating profit (EBIT)
1352.81%
EBITDA
584.07%
Net Profit (Loss) for the Period
1388.39%
Total assets
10.72%
Total equity
29.42%
Operating Profit Margin (ROS)
34.05%
Net Profit Margin
30.49%
Return on Equity (ROE)
20.88%
Quick Ratio
0.33%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?